Journal of Molecular Biology

Year	IMPACT-FACTOR
2022	1,200
2021	1,540
2020	1,374
2019	1,023
2018	0,932
2017	0,977
2016	0,799
2015	0,662
2014	0,740
2013	0,739
2012	0,637
2011	0,658
2010	0,654
2009	0,570
2008	0,849
2007	0,805
2006	0,330
2005	0,435
2004	0,623
2003	0,567
2002	0,641
2001	0,490
2000	0,477
1999	0,762
1998	0,785
1997	0,507
1996	0,518
1995	0,502

Vol 51(2017) N 6 p. 769-771; DOI 10.1134/S0026893317060085

D.V. Kuprash^1,2, F.Yu. Garib^2,3,4, S.A. Nedospasov^1,2*

Antibody-Based Drugs and Other Recombinant Proteins for Diagnostics and Therapy of Viral Infections, Autoimmune Diseases and Cancer
¹Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia
²Department of Immunology, Biological Faculty, Moscow State University, Moscow, 119991 Russia
³Department of Immunology, Russian Medical Academy of Postgraduate Education, Moscow, 123995 Russia
⁴Department of Clinical Immunology and Allergology, Sechenov First Moscow State Medical Institute, Moscow, 119991 Russia

^*sergei.nedospasov@gmail.com
Received - 2017-07-25; Accepted - 2017-07-25

Immunoglobulins, catalytic antibodies, chimeric antigenic receptors, targeted therapy, immunotherapy, targeted delivery